Forsta Ap-Fonden’s Edwards Lifesciences Corp Position
Does Forsta Ap-Fonden own Edwards Lifesciences Corp (EW)? Not currently — the last reported position was 126.2K shares worth $11M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$11M
Q4 2025
Shares
126.2K
% of Portfolio
+0.06%
Quarters Held
24
position exited
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 126.2K | $11M | +0.06% |
| Q3 2025 | 129.0K | $10M | +0.06% |
| Q2 2025 | 121.3K | $9M | +0.06% |
| Q1 2025 | 122.2K | $9M | +0.07% |
| Q4 2024 | 130.1K | $10M | +0.07% |
| Q3 2024 | 134.0K | $9M | +0.07% |
| Q2 2024 | 119.6K | $11M | +0.10% |
| Q1 2024 | 146.1K | $14M | +0.12% |
| Q4 2023 | 133.5K | $10M | +0.10% |
| Q3 2023 | 118.8K | $8M | +0.09% |
| Q2 2023 | 118.8K | $11M | +0.12% |
| Q1 2023 | 124.9K | $10M | +0.12% |
| Q4 2022 | 151.3K | $11M | +0.13% |
| Q3 2022 | 183.1K | $15M | +0.19% |
| Q2 2022 | 182.8K | $17M | +0.23% |
| Q1 2022 | 185.5K | $22M | +0.25% |
| Q4 2021 | 162.6K | $21M | +0.21% |
| Q3 2021 | 148.5K | $17M | +0.19% |
| Q2 2021 | 160.5K | $17M | +0.20% |
| Q1 2021 | 134.3K | $11M | +0.16% |
| Q4 2020 | 125.3K | $11M | +0.17% |
| Q3 2020 | 107.4K | $9M | +0.18% |
| Q2 2020 | 85.1K | $6M | +0.15% |
| Q1 2020 | 23.6K | $4M | +0.16% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Forsta Ap-Fonden’s full portfolio or all institutional holders of EW.